Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Tasly Pharmaceutical describes platelet aggregation inhibitors

Jan. 13, 2017

Wockhardt reports antibacterial activity enhancers

Jan. 13, 2017

Bayer describes BUB1 inhibitors for cancer

Jan. 13, 2017

Servier and Vernalis jointly patent Mcl-1 inhibitors

Jan. 13, 2017

Chongqing University reports PDE5A inhibitors

Jan. 13, 2017

FASN inhibitors reported in Teva patent

Jan. 13, 2017

Kissei Pharmaceutical describes TRPM8 antagonists

Jan. 12, 2017

Takeda reports M1 PAMs for Alzheimer's disease

Jan. 12, 2017

Bayer patents anticancer compounds

Jan. 12, 2017

Apodemus prepares and tests PI4Kbeta inhibitors

Jan. 11, 2017

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...